News | Artificial Intelligence | April 01, 2020

Dutch companies Offer Free Innovative COVID-19 AI Software

This new artificial intelligence (AI) tool analyses X-ray images and is intended to support healthcare specialists manage COVID-19 cases
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

CAD4COVID will generate a score between 0 and 100 indicating the extent of COVID-19 related abnormalities, display such lung abnormalities through a heatmap and quantify the percentage of the lung that is affected.

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 A brief article from Henry Ford Health System in Detroit, published today in Radiology, reports on the first presumptive case of COVID-19–associated acute necrotizing hemorrhagic encephalopathy.

CAD4COVID will generate a score between 0 and 100 indicating the extent of COVID-19 related abnormalities, display such lung abnormalities through a heatmap and quantify the percentage of the lung that is affected.

April 1, 2020 — Thirona and Delft Imaging launched CAD4COVID. This new artificial intelligence (AI) tool analyses X-ray images and is intended to support healthcare specialists manage COVID-19 cases. The companies have made the tool available free-of-charge in support of the crisis. Thirona and Delft Imaging are partnering with several hospitals and academic institutes worldwide to validate CAD4COVID.

Artificial Intelligence for COVID-19 Triage

Delft Imaging is specialised in tuberculosis (TB) screening and with its existing CAD4TB solution, which uses artificial intelligence to screen for TB. Over six million people have been screened in over 40 countries. Together with its sister company and AI-specialist Thirona, Delft Imaging developed a tool to help triage COVID-19 cases and indicate the affected lung tissue. CAD4COVID builds on the technical core of the CAD4TB software, developed and distributed by Thirona and Delft Imaging respectively. This software is used by Ministries of Health and tuberculosis-focused institutions, many of whom are now being tasked with helping to stop the spread of COVID-19 in their respective countries.

Continuous Improvement

Preferred tools in the detection of COVID-19 are the RT-PCR test and the computed tomography (CT) scan, but in resource-constrained settings where the availability of such tools is limited and where COVID-19 is highly prevalent, X-ray can be a useful tool in the fight against COVID-19. In many countries, X-ray is currently used as a first-line triage before any further testing. Delft Imaging and Thirona have partnered with several academic institutes and hospitals in the Netherlands and abroad. These organisations will help with the development and validation of the software to support healthcare professionals in these times of crisis. The two Dutch companies aim to continuously improve the CAD4COVID software as more partners sign up.

Supporting Low-resource Settings

Guido Geerts, CEO of Delft Imaging and Thirona, about CAD4COVID: “Tuberculosis still takes the lives of 1.6 million people every year. It is incredibly challenging to tackle, especially as it is most active in low-resource settings where there is limited infrastructure. Our breadth of experience in such settings has made us very concerned about the implications that COVID-19 can have on countries where healthcare infrastructure is already under pressure. Many of the measures implemented across Europe and the United States will be difficult to replicate in Africa. How can you quarantine in a small household full of people? How do you ‘stock-up’ when you live day-to-day? We wanted to leverage our expertise and experience in artificial intelligence to support the fight against COVID-19. That is also why we decided to make CAD4COVID available free-of-charge; in order to end this pandemic, we need to have a big impact, quickly.”

For more information: www.thirona.eu, www.delft.care

Related Coronavirus Content:

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

Related Content

 Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets whilst working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts th

Doctors wearing the Hololens Device. Source: Imperial.ac.uk

News | Artificial Intelligence | May 22, 2020
May 22, 2020 — Recently the versatility of
Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm).

Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm). Image courtesy of The New England Journal of Medicine

News | Coronavirus (COVID-19) | May 22, 2020
May 22, 2020 — In a new study in the New
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).

Getty Images

News | Coronavirus (COVID-19) | May 21, 2020
May 21, 2020 — Despite facing challenges such as limited access to...
Remote reading of imaging studies on home picture archiving and communication systems (PACS) workstations can contribute to social distancing, protect vulnerable radiologists and others in the hospital, and ensure seamless interpretation capabilities in emergency scenarios, according to an open-access article published ahead-of-print by the American Journal of Roentgenology (AJR).

Srini Tridandapani, M.D., Ph.D.

News | PACS | May 21, 2020
May 21, 2020 — 
In response to the significant healthcare delivery changes brought on by COVID-19, Varian has launched new capabilities for its Noona software application, a powerful tool designed to engage cancer patients in their care for continuous reporting and symptom monitoring.
News | Radiation Oncology | May 21, 2020
May 21, 2020 — In response to the significant healthcare delivery changes brought on by...
NucleusHealth, a provider of cloud-based medical image management technology and teleradiology services, announced today that it has received Conformité Européene (CE) Mark approval for Nucleus.io.
News | Teleradiology | May 21, 2020
May 21, 2020 — NucleusHealth, a provider of cloud-based medical image management technology and teleradiology service
Actionable insight “beyond the diagnosis” enables health researchers to better understand COVID-19 progression, intervention effectiveness, and impacts on healthcare system
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 — Change Healthcare introduced ...
Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 —Atrium Health is one of the first major health systems in the nation to put into wide practice a new...